Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group (Q70681088)
Jump to navigation
Jump to search
scientific article published on 01 May 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group |
scientific article published on 01 May 1993 |
Statements
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group (English)
J W Singleton
S B Hanauer
G L Gitnick
M A Peppercorn
M G Robinson
L D Wruble